What Happens Inside Your Blood When Chronic Myeloid Leukaemia Grows

A blood test can show a problem even before the body sends any obvious signals. A person might see their doctor for another issue, have a standard blood count, and find their white blood cell level abnormally high. As a result of further tests, a diagnosis of chronic myeloid leukaemia (CML), which is a form of blood cancer originating in the bone marrow, may be reached.

At this stage, it’s natural to ask: what is actually going on inside the body? The explanation lies in blood cell formation and what happens when the instructions that control their growth are incorrect.

Key Takeaways

• CML develops due to a genetic change that produces the abnormal BCR::ABL1 protein.

• Uncontrolled white blood cell growth disrupts normal blood cell production.

• CML progresses through chronic, accelerated and blast phases.

• Targeted medicines help control abnormal cell growth.

• Regular blood tests and molecular monitoring help track treatment response.

When Blood Cell Production Loses Its Balance

The body’s bone marrow produces the cells that enable the body to function properly. Red blood cells carry oxygen, white blood cells help defend against infections, and platelets help stop bleeding after an injury. Although each cell type has a separate function, their production must remain balanced.

CML interferes with this process by causing a genetic alteration in the cells that give rise to blood. In most cases, sections of chromosomes 9 and 22 swap places, creating the Philadelphia chromosome. This in turn produces an abnormal gene known as BCR::ABL1.

This change causes the affected cells to behave abnormally. The gene produces an abnormal protein called a tyrosine kinase; this protein constantly signals the cells to grow and divide. Because the bone marrow does not receive the correct instructions to reduce this activity, white blood cells keep accumulating.

Large numbers of these cells can enter the bloodstream. As a result, a blood test may show a significant rise in white blood cells even if the individual has not noticed any major change in their health.

Why More White Blood Cells Do Not Mean Better Health

White blood cells usually help protect the body from infection; in CML, the extra cells result from an abnormal genetic signal rather than the body needing more protection, and their large number does not necessarily mean the immune defence is more effective.

The effects can also affect other blood cells; as the abnormal cells increase in number, the production of normal blood cells may be disturbed. For example, the red blood cells might fail to provide the body with the oxygen it needs.

It is therefore understandable why a person with CML may feel tired even if they are getting sufficient sleep. Anaemia can cause constant fatigue, weakness, or shortness of breath during ordinary activities. In some cases, these changes are noticed slowly and individuals might at first attribute them to stress or to their hectic routine.

Platelets may be affected in another way: in the early stages of the disease, their number might increase, though it can decrease as the disease advances. Because platelets play a role in blood clotting, these changes matter. The risk of bleeding or clotting complications may increase if levels are abnormal, depending on the test results and the person’s situation.

The spleen could also change in this way. Its function is to filter the blood and to help get rid of old or abnormally shaped cells. If it enlarges, a person might feel discomfort under the left ribs or feel full after eating only a small amount. However, not everyone experiences these symptoms, and they can also be associated with other diseases.

What occurs when CML advances?

CML behaves differently in different individuals, and doctors divide it into chronic, accelerated, and blast phases to describe how the condition progresses.

In the chronic stage, the disease may cause only a few symptoms. People sometimes find out that they have CML as a consequence of an abnormal blood test. In other cases, they may feel tired, sweat at night, or lose weight without knowing why.

As the disease progresses, the number of immature white blood cells, known as blasts, may start to rise. These cells have not developed into mature and functioning blood cells. During the blast phase, they can multiply quickly and push healthy cells out of the bone marrow, making the disease harder to control.

Doctors do not base their judgment on symptoms alone when deciding whether CML is progressing. They use blood counts, the ratio of immature cells, and specific molecular tests to better understand the situation.

How Treatment Targets the Abnormal Cells

Understanding the genetic alteration that causes CML has made targeted treatment possible; rather than affecting cells throughout the body, tyrosine kinase inhibitors target the abnormal protein responsible for the condition.

Imatinib is one of the medicines used to treat CML since it inhibits the activity of the BCR::ABL1 protein and thus helps to reduce the growth of the affected cells. As treatment takes effect, blood counts may rise, and the number of cells with the abnormal genetic change may decrease.

Although an Imanib tablet is linked with imatinib treatment, patients must check with their doctor or pharmacist to make sure they have the correct product, strength and dosage. The choice of treatment will depend on the diagnosis, the results of the tests and the individual’s response. One should never stop or change a prescribed medicine without first obtaining medical advice.

Conclusion

Understanding what happens inside the blood when chronic myeloid leukaemia develops helps explain why early diagnosis, regular blood tests and consistent treatment matter. Although CML affects the way blood cells are produced, targeted medicines can help control the condition when prescribed appropriately. Keeping up with follow-up appointments and discussing any new symptoms with a healthcare professional can support better long-term management.

Disclaimer: This article is intended for educational purposes only and should not be considered medical advice. Diagnosis and treatment decisions for CML should always be made in consultation with a qualified healthcare professional. Do not start, stop or change any prescribed medicine without medical guidance.